Top Markets
Coin of the day
The Greater Cannabis Company, Inc. The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc.

GCAN
Classifica tra le azioni #40153
The Greater Cannabis Company, Inc. engages in the development and... The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.
Prezzo delle azioni
$0.2301
Ultima sincronizzazione: 2026-08-12
Capitalizzazione di mercato
$228.81K
Variazione (1 giorno)
-17.82%
Variazione (1 anno)
95,775.00%
Paese
US
Scambia The Greater Cannabis Company, Inc. (GCAN)

Categoria

Storico del rendimento da dividendi per The Greater Cannabis Company, Inc. (GCAN)
Il rendimento da dividendi (TTM) di The Greater Cannabis Company, Inc. (simbolo azionario: GCAN) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per The Greater Cannabis Company, Inc. (GCAN) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti